Optipharm Co., Ltd. (153710)

Overview

Optipharm.CO.,LTD, headquartered in Cheongju, South Korea, stands as a leading biomedical solution provider with a foundation dating back to 2000. Initially known as Optiparm Solution Co., Ltd., it underwent a name change in 2012 to better reflect its expanded scope and ambitions. The company has carved a niche in the biomedical field, focusing on a wide array of biotechnological solutions and services tailored towards both human healthcare and veterinary applications. With its extensive expertise, Optipharm.CO.,LTD dedicates itself to advancing medical science and animal health, leveraging cutting-edge research and development to tackle various challenges in the industry.

Products and Services

Optipharm.CO.,LTD provides an expansive range of products and services designed to cater to the diverse needs of the biomedical and veterinary sectors:

• Animal Disease Diagnosis: Specializing in the precise detection and diagnosis of diseases in animals, which is crucial for effective treatment and management of animal health.
• Animal Medicine: Development and distribution of pharmaceuticals specifically formulated for animals, addressing a wide spectrum of conditions to improve and maintain their health.
• Bacteriophage: Utilizing bacteriophages in innovative treatments and therapies, offering alternatives to conventional antibiotics in battling bacterial infections.
• Medipig: The ‘Medipig’ program focuses on the development and care of genetically engineered pigs for medical research, including organ transplantation and pharmacology.
• Xenogenic Organs: Advancing xenotransplantation with the development of animal organs that are genetically modified for transplantation into humans, to address the critical shortage of human donor organs.
• VLP Vaccines: Engaging in the creation of virus-like particle (VLP) vaccines, an innovative approach in vaccine development that offers greater safety and efficacy.
• Xenotransplantation: Leading efforts in xenotransplantation research and implementation, aimed at resolving the gap between the demand and supply of donor organs through the use of animal organs.
• Optipharm Products: Offering a diverse portfolio of proprietary products across the healthcare and veterinary sectors, including but not limited to, additives, treatments, and diagnostic tools.
• Veterinary Drug for Feed Additives: Producing specialized veterinary drugs that are added to animal feed, promoting the health and growth of livestock and other animals.
• Laboratory Animal Medipig Business: Not only focused on the Medipig program for medical research but also commercializing the bred animals for laboratory purposes, ensuring high-quality and standardized specimens for scientific research.